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Abstract: 
 
Dermatoglyphic anomalies are hypothesized to indicate disruptions in the second trimester of 
prenatal development, a time period that appears to be critical in the etiology of schizophrenia. 
The present study examined the presence of dermatoglyphic anomalies in psychometrically 
identified schizotypic young adults (n=51) and control participants (n=63) selected based upon 
their scores on the Perceptual Aberration [J. Abnorm. Psychology 87 (1978) 399] and Magical 
Ideation Scales [J. Consult. Clin. Psychol. 51 (1983) 215]. It was hypothesized that schizotypic 
participants would exhibit higher rates of dermatoglyphic anomalies than control participants. 
The Perceptual Aberration–Magical Ideation group exhibited lower total and absolute finger 
ridge counts and less complex pattern types than control participants—findings consistent with 
anomalies reported in patients with schizophrenia. These findings encourage future examination 
of these anomalies in individuals at-risk for schizophrenia and related disorders. 
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Article: 
 
The reliable identification of individuals who are at-risk for schizophrenia and related disorders 
should increase our understanding of the etiology of such conditions, and may foster the 
development of preventative treatment interventions. Current etiological models of schizophrenia 
(e.g., Meehl, 1990, Gottesman, 1991 and Andreasen, 1986) assume that the disorder arises from 
an interaction or accumulation of multiple risk factors, including genetic inheritance, gene 
expression, pre- and peri-natal insults, and other biopsychosocial stressors. These models 
explicitly or implicitly assume that there is a dynamic continuum of schizotypic adjustment with 
full-blown schizophrenia at the severe end of the continuum. Furthermore, these models suggest 
the existence of schizotypic individuals who have a vulnerability for schizophrenia and related 
disorders. However, it is hypothesized that the majority of these individuals will not develop 
schizophrenia, although they may experience attenuated or transient symptoms of the disorder 
and may genetically transmit this risk to their offspring (e.g., Gottesman and Bertelsen, 1989). 
These symptoms are presumed to fall on a continuum from relative health to subclinical deviance 
to schizophrenia-spectrum personality disorders to full-blown clinical psychosis. Thus, 
schizotypy appears to be expressed across a dynamic continuum of adjustment with severity 
modulated by the interaction of biopsychosocial factors (Gooding and Iacono, 1995). 
 
Schizotypy (and consequently the vulnerability for schizophrenia) is presumed to arise from 
processes of neural dysmaturation beginning during the second trimester of gestation (e.g., 
Andreasen, 1986, Keshavan, 1997 and Weinberger, 1987). While genetic factors are likely the 
largest contributors to prenatal neural dysmaturation, a variety of other adverse prenatal events 
can disrupt neurodevelopment and likely contribute to the risk for schizophrenia and related 
disorders, such as exposure to the influenza virus Mednick et al., 1988, Barr et al., 1990 and 
O'Callaghan et al., 1991b, increased psychological distress, and famine Huttunen and Niskanen, 
1978 and Susser et al., 1996. 
 
The proposed mechanism for increased risk for schizophrenia due to prenatal insults is a 
disruption of cell migration that leads to brain formation, which largely occurs during the second 
trimester of pregnancy. Neurohistological studies involving posthumous examination of the 
brains of patients with schizophrenia and control participants provide evidence of cell 
disorientation and misplacement in schizophrenia Conrad et al., 1991, Conrad and Scheibel, 
1987, Arnold et al., 1991 and Selemon et al., 1995. Prenatal disruptions in brain formation could 
lead to further neural dysmaturation during childhood and adolescence (e.g., disruptions in 
synaptic pruning during adolescence). Thus, it appears that prenatal disruptions set in motion a 
pattern of neural dysmaturation that can manifest in adolescence and adulthood as schizophrenia 
(Andreason, 1999). 
 
Dermatoglyphic anomalies and schizophrenia 
 
Prenatal neural development during the second trimester of gestation is accompanied by 
formation of the much of the ultimate ectoderm. In fact, these two processes are inextricably 
intertwined. For example, the neural tube develops from the elementary ectoderm, and the lumen 
of the neural tube goes on to develop into the ventricular system of the brain. Thus, if risk for 
schizophrenia were heightened by disruptions affecting neurodevelopment, one would surmise 
that these disruptions might also be noted on the ultimate ectoderm (O'Connell et al., 1997). 
Consistent with these hypotheses, there is extensive evidence that disruptions in skin formation 
on the fingers and palms are more common in patients with schizophrenia than in samples of 
individuals without schizophrenia. These differences in ectoderm development are generically 
referred to as “dermatoglyphic anomalies” and can be categorized into two distinct groups: (1) 
qualitative and/or quantitative differences in finger and palmar ridge formation characteristics 
(e.g., people with schizophrenia may have higher or lower overall finger ridge counts than 
control participants), and (2) fluctuating dermatoglyphic asymmetries (FDA), which are defined 
as random differences between homologous finger and palmer ridge characteristics (e.g., 
individuals with schizophrenia are reported to have a higher degree of asymmetry between finger 
pairs than control participants). 
 
Patients with schizophrenia have been found to differ from controls on a variety of 
dermatoglyphic measures. Table 1 provides a synopsis of the empirical literature investigating 
the role of dermatoglyphic anomalies in individuals with psychotic disorders. While it is clear 
that the majority of investigations have yielded significant findings, some studies have indicated 
no significant differences Cantor-Graae et al., 1998 and Rosa et al., 2000b and others have 
yielded very small differences. For example, Mellor (1992) reported higher rates of fluctuating 
dermatoglyphic asymmetry (FDA) among patients with schizophrenia for finger ridge counts, 
fingerprint patterns, palmar angles, and palmar ridge counts in comparison to control 
participants. However, the observed differences in the study were modest (e.g., a group of 482 
patients with schizophrenia had 23.1% of their finger pairs discordant compared to a control 
group of 166 participants, who had 18% of their finger pairs discordant). 
 
TABLE 1 OMITTED FROM THIS FORMATED DOCUMENT 
 
Furthermore, few investigations have examined dermatoglyphic anomalies in those at-risk for 
schizophrenia. In order to be a valid marker, dermatoglyphic anomalies should be present in the 
prodromal, active, and residual phases of schizophrenia (consistent with the recommendations of 
Garver, 1987), and should be found at higher rates in schizotypic individuals and in patients with 
schizophrenia-spectrum disorders (i.e., disorders such as schizotypal personality disorder that are 
thought to be etiologically related to schizophrenia). Weinstein et al. (1999) have provided 
evidence that individuals with schizotypal personality disorder have higher absolute finger ridge 
count asymmetry than control participants; however, this was the only dermatoglyphic index 
they investigated. Furthermore, Rosa et al. (2000c) found that degree of FDA was positively 
correlated with the negative dimension of schizotypy among a sample of adolescent males, 
although no such relation existed among positive dimensions of schizotypy. 
 
Dermatoglyphic anomalies and other forms of pathology 
 
In addition to schizophrenia, dermatoglyphic abnormalities have been associated with epilepsy, 
Down's syndrome, mental retardation, neurofibromatosis, spina bifida, polydactyly (Cummins 
and Midlo, 1943), congenital heart disease (Hale et al., 1961), borderline personality disorder 
(Jelovac et al., 1995), and autism (Walker, 1977). Although dermatoglyphic anomalies are not 
unique to schizophrenia, it is hypothesized that examining these characteristics in a population of 
schizotypic individuals may further enhance our ability to identify individuals at risk for 
schizophrenia and related disorders. 
 
Goals and hypotheses of the present study 
 
The present study examined the presence of dermatoglyphic anomalies in schizotypic college 
students and control participants identified by scores on the Perceptual Aberration (Chapman et 
al., 1978) and Magical Ideation Scales (Eckblad and Chapman, 1983). Consistent with Garver's 
guidelines for robust markers of psychosis (1987), we hypothesized that dermatoglyphic 
anomalies would be found at a higher rate in schizotypic young adults than in a control sample. It 
should be noted that dermatoglyphic anomalies are thought to be a “gross marker” of a 
contributory risk factor (nonspecific disruption of prenatal development during the second 
trimester of gestation). Thus, our current knowledge about dermatoglyphic anomalies does not 
allow us to comment on the exact nature or severity of prenatal developmental disruptions 
(events which are neither necessary, nor sufficient, causes of schizotypy). Therefore, we do not 
offer hypotheses regarding specific types of anomalies or about the overall frequency of 
anomalies in our schizotypic sample. However, the presence of dermatoglyphic anomalies in 
psychometrically identified schizotypic samples may facilitate the identification of individuals at 
risk for schizophrenia and move us closer to understanding their potential association with the 
etiology and development of schizotypy. 
 
Methods 
 
Participants 
 
The Perceptual Aberration and Magical Ideation Scales were administered to approximately 
1200 undergraduate students enrolled in general psychology courses at the University of North 
Carolina at Greensboro over the course of three semesters. Fifty-one schizotypic participants, 
identified by standard scores of at least +1.96 on either of the scales, and 63 control participants 
who received standard scores of less than +0.5 on both scales participated in the dermatoglyphic 
assessment. The selection procedures followed the recommendations of Chapman et al. (1995). 
Control participants were selected from among a larger pool of candidate participants using a 
semi-random procedure. When a Perceptual Aberration–Magical Ideation participant was 
identified, the next comparison participant on a sequential list was selected. Ninety-two percent 
of the students contacted agreed to participate in the dermatoglyphic assessment. The 
participants were limited to Caucasian and African American students because normative data on 
the schizotypy scales were not available for other ethnic groups. Table 2 provides demographic 
information for the participants. The groups did not differ on any of these characteristics. 
 
 
 
Materials 
 
Screening questionnaires 
 
The Perceptual Aberration and Magical Ideation Scales were intermixed with a 13-item 
infrequency scale (Chapman and Chapman, 1983) that was designed to screen out random or 
“fake-bad” response styles. Participants who endorsed three or more items on the infrequency 
scale were omitted from participation in the dermatoglyphic assessment. The Perceptual 
Aberration Scale consists of 35 items that tap schizophrenic-like perceptual experiences and 
bodily distortions. Sample items include, “I sometimes have the feeling that some parts of my 
body are not attached to the rest of me” [keyed true], and “My hands and feet have never seemed 
far away” [keyed false]. The Magical Ideation Scale is made up of 30 items that measure belief 
in implausible or invalid causality. Sample items include: “I have occasionally had the silly 
feeling that a TV or radio broadcaster knew I was listening to him” [keyed true], and “Numbers 
like 13 and 7 have no special powers” [keyed false]. The scales were constructed using Jackson's 
(1970) method for rational scale development. The coefficient alpha internal consistency 
reliability was 0.88 for the Perceptual Aberration Scale and 0.84 for the Magical Ideation Scale 
in the screening sample. The Perceptual Aberration and Magical Ideation Scales have been used 
widely in cross-sectional and longitudinal studies of schizotypy. Groups identified as at-risk by 
these measures show psychological and physiological deficits similar to those seen in patients 
with schizophrenia and are at heightened risk for developing psychotic disorders (e.g., Chapman 
et al., 1994 and Chapman et al., 1995). 
 
Assessment of dermatoglyphic anomalies 
 
Twelve different finger and palmar measures of dermatoglyphic anomalies were completed for 
each participant. A triradius is present when three disparate ridges come together at 
approximately 120° angles (Holt, 1968). Finger ridge counts were determined by counting the 
number of ridges that intersected a straight line connecting the triradial point (the point of ridge 
intersection) to the point of the core (the ridge in the center of the pattern). If more than one 
triradius was present on a finger, multiple ridge counts were made (e.g., two triradii yielded two 
ridge counts). The ridges containing the point of the core and the triradial point were not 
included in this computation. Total finger ridge count (TFRC) was computed by summing the 
ridge counts of all 10 fingers, in which only the largest count was used on those digits with more 
than one ridge count. Absolute finger ridge count (AFRC) was determined by adding all of the 
ridge counts from each of the 10 fingers (including multiple ridge counts for fingers with two or 
more triradii). Palmar a–b ridge count was determined by counting the number of ridges that 
crossed a straight line drawn between the “a” and “b” triradii of the palm. The “a” area is the part 
of the palm just below the index finger and the “b” area is the part of the palm just below the 
middle finger. Parts “c” and “d” of the palm (located beneath the ring and last fingers, 
respectively) were not used for counting ridges because the ridges in these areas are often 
parallel to the line that is drawn to connect the triradii. Palmar atd angle was determined by 
measuring the angle formed when drawing a line from the palmar “a” triradius to the most distal 
“t” triradius at the base of the palm and then from that triradius to the palmar “d” triradius. 
 
The frequency of pattern type on the fingers was also computed. Finger patterns were classified 
into three categories: (1) arches, which do not typically contain a triradius; (2) loops, which are 
characterized by a triradius that opens towards a side of the hand, and a core; (3) and whorls, 
closed patterns characterized by having at least two triradii and a core(s). In rare cases, an arch 
contains a triradius, but it always lacks a core, which precludes making a ridge count (and 
distinguishes them from loops and whorls). We also examined prints for signs of ridge 
dissociation, although none of the participants in the present study exhibited this severe anomaly. 
 
Four FDA measures were computed for the participants by examining discrepancies between 
measures on the right and left hands or between homologous fingers. Because our hypotheses 
involved the degree of asymmetry, not the direction of lateralization, we used the absolute value 
of the discrepancies to compute FDA measures. Fluctuating asymmetry was determined for 
TFRC and AFRC by comparing the relevant ridge counts of homologous fingers. The absolute 
differences for each of the five-finger pairs were summed to compute the asymmetry score. 
Fluctuating asymmetry of the palmar a–b ridge count was measured by taking the absolute 
difference between the right hand a–b ridge count and the left hand a–b ridge count. Likewise, 
palmar atd angle asymmetry was measured by taking the absolute difference between atd angles 
from the right and left hands. 
 
Finger and palmar prints were made by one graduate and four undergraduate researchers using 
Perfect Ink printing apparatus (provided by Identicator, www.identicatorinc.com). Prints were 
scanned using a Visioneer 8900 USB scanner at 600 dpi and images were enlarged to over 600% 
using the “zoom” tool on Adobe Photoshop to provide a clear and accurate image of the prints 
for scoring. The “line-drawing” tool was also used to make a precise connection between the 
triradial point and the core. This tool also helped to minimize visual drifting, which can occur 
when trying to count ridges as the experimenter moves from the triradial point to the core. 
Varying density of ridges and other dermatoglyphic features that are often very minute in nature, 
such as interestial lines and islands, can easily be erroneously included in a ridge count if a 
precise line is not in place. Interrater reliability was assessed based upon prints from 72 
participants that were scored independently by two trained raters. Disagreements were resolved 
by consensus for the purpose of subsequent analyses. The schedulers, examiners, and scorers 
were unaware of participants' group membership throughout the study. 
 
Results 
 
Table 3 presents the interrater reliability (intraclass correlations) for each of the dermatoglyphic 
measures. Table 4 presents the comparisons of the Perceptual Aberration–Magical Ideation and 
control groups on the dermatoglyphic measures. The schizotypy group had a significantly lower 
TFRC, AFRC, and number of whorls than the control group, and significantly more loops. The 
groups did not differ on either of the palmar measures. Likewise, the groups did not differ on any 
of the FDA comparisons. The effect sizes, as estimated by Cohen's d, were relatively small for 
all of the comparisons. While the groups did not differ on sex or ethnic composition, the analyses 
were re-run as stepwise regression analyses with these demographic characteristics entered at 
step one and group membership entered at step two. Significant effects were found for the 
demographic characteristics on only two of the 11 measures (number of loops and FDA TFRC). 
In both cases the effect resulted from Caucasian participants exceeding African American 
participants. The effects for group membership were substantially unchanged, although the 
difference on number of loops was only at the trend level (p=0.06). 
 
 
 
 
 
Discussion 
 
The present study investigated the presence of dermatoglyphic anomalies in psychometrically 
identified schizotypic college students. It represents one of the first systematic assessments of 
dermatoglyphic characteristics in a nonclinical sample presumed to be at risk for schizophrenia 
and related conditions. The finding of such characteristics would support the utility of 
dermatoglyphic anomalies as a marker of risk for schizotypy and potentially facilitate the 
identification of individuals at risk for schizophrenia and related disorders. Consistent with 
primary hypothesis of the study, students identified by the Perceptual Aberration and Magical 
Ideation Scales differed from control participants on measures of finger ridge counts and 
displayed fewer complex fingerprint patterns. However, the groups did not differ on the palmar 
measures or on the FDA measures. 
 
While the findings of an increased prevalence of dermatoglyphic anomalies in a schizotypic 
sample are concordant with Rosa et al.'s (2000c) demonstration of greater FDA in adolescents 
with higher schizotypy scores, the specific anomalies that were present differ across these 
studies. For example, both the current investigation and Rosa et al. found no relation between 
FDA and positive schizotypy. However, the current study did find reduced TFRC and AFRC 
among positive schizotypes in comparison to control participants. This suggests that while 
symmetry may be intact among those with positive schizotypy, other anomalies, such as reduced 
finger ridge count, may be evident and representative of similar prenatal disturbances. FDA on 
the other hand, which was found to be related to negative schizotypy in the Rosa et al. study, 
may be more germane to prenatal disruptions in negative schizotypes, which were not examined 
in the current investigation. 
 
One possible explanation for the mixed findings involves the nature of the present sample. The 
current investigation employed a sample of college students at-risk for schizophrenia. While a 
number of longitudinal studies (e.g., Chapman et al., 1994 and Kwapil, 1998) have demonstrated 
that psychometrically identified college students are at heightened risk for psychotic and 
spectrum disorders, they provide a conservative sample and likely underestimate the utility of 
this research method. Specifically, college students represent the healthiest members of their age 
cohort in terms of risk for schizophrenia. Presumably, many schizotypic individuals (especially 
those who will ultimately develop schizophrenia) will experience impaired functioning and 
limited resources in late adolescence that will prevent them from enrolling in college and 
participating in such studies. The Epidemiological Catchment Area Study (Robins et al., 1984) 
indicated that college-educated individuals have a lower risk of developing schizophrenia than 
their peers without a college education. It may be that the presence of dermatoglyphic anomalies 
is associated with significant neurocognitive deficits and psychosocial stressors that might lessen 
the likelihood of enrollment in college. Therefore, the schizotypic sample employed in the 
current study may exhibit fewer dermatoglyphic anomalies than schizotypic samples selected 
from the general population (this notion is consistent with a multiple-hit model of risk). Indeed, 
some researchers have suggested that the rate of dermatoglyphic anomalies is associated with 
symptom severity. For example, Markow and Wandler (1986) found that more severe cases of 
schizophrenia, as indicated by early age of onset and declining course of illness, were correlated 
with the degree of fluctuating dermatoglyphic asymmetry. It should also be noted that the palmar 
and FDA measures, which did not differ between the groups, tended to have lower reliability 
than the other measures. 
 
Consistent with previous studies of schizophrenic patients, the values of Cohen's d reported in 
the current study suggest that the effect sizes for differences between schizotypic and control 
groups are relatively modest in college student samples. While the sample size was sufficient to 
detect medium effect sizes (as in the case of AFRC and whorls), the sample was underpowered 
for detecting small effect sizes reported for the FDA measures. While dermatoglyphic anomalies 
may be less frequent in college samples of schizotypes, it does not necessarily rule out their 
utility for identifying individuals at risk for schizophrenia and related disorders (even in college 
student samples). We are currently examining the degree to which dermatoglyphic anomalies 
increment the cross-sectional identification and longitudinal prediction of symptoms and 
neurocognitive deficits in psychometrically identified schizotypes. 
 
The theory behind the co-occurrence of dermatoglyphic anomalies and schizophrenia is based on 
the idea that the lumen of the neural tube, which later becomes the ventricular system and 
substance that makes up the brain, develops from the rudimentary ectoderm. Therefore, if 
schizophrenia is the result of a developmental brain disorder, we would expect to see anomalies 
in the formations of the skin in a subset of patients. Taken together with the empirical literature 
that has linked fluctuating asymmetry with weakened developmental stability, dermatoglyphic 
anomalies appear to be a promising marker for a developmental disturbance in the prenatal 
environment that may increase the risk for schizophrenia. While the base rate of dermatoglyphic 
anomalies may be relatively low in the present sample, they may identify a subset of individuals 
at especially heightened risk for developing schizophrenia and related disorders. The present 
study provides the first step in examining dermatoglyphic anomalies in a nonclinical sample and 
should provide the foundation for examining the relationship between these characteristics and 
schizotypic symptoms. 
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